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Case Report
A Case of Cholesterosis Bulbi with Secondary Glaucoma 
Treated by Vitrectomy and Intravitreal Bevacizumab
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We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history 
of long-standing retinal detachment in his right eye after the irrigation and aspiration of a congenital cataract, pre-
sented with a clinical picture of elevated intraocular pressure and ocular pain. Upon slit-lamp examination, we found 
a ciliary injection and a pseudohypopyon of polychromatic crystals. Gonioscopic examination revealed a large 
amount of crystals deposited on the trabecular meshwork and mild rubeosis iridis, but the neovascularization of the 
angle could not be clearly confirmed due to the presence of so many crystals. Pars plana vitrectomy was performed 
to remove clusters of crystals and bevacizumab was injected intravitreally to treat iris neovascularization. Aqueous 
aspirate was examined by light microscopy and the typical highly refringent cholesterol crystals were identified. 
Intraocular pressure returned to a normal level after the bevacizumab injection, although severe cholesterosis was 
still evident in the anterior chamber. To our knowledge, this would be the first Korean case of cholesterosis bulbi 
combined with chronic retinal detachment and presumed neovascular glaucoma, which was treated by pars plana 
vitrectomy and intravitreal bevacizumab injection. 
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Cholesterol crystals of the anterior chamber is a rare con-
dition that can be found as a marked feature of advanced cho-
lesterosis bulbi [1]. Cholesterosis bulbi is known as a con-
dition characterized by many crystalline bodies suspended in 
the vitreous body or the anterior chamber of blind eyes or 
those with long-term damage [2]. This condition can occur 
typically following long-standing retinal detachment (RD), 
severe ocular trauma, intraocular hemorrhage, advanced 
Coats’ disease, etc [3,4]. 
A considerable number of cholesterosis bulbi cases have 
been treated by enucleation due to intractable pain and the 
further danger of sympathetic ophthalmia in the other eye 
[3-6]. Here, we report on the first Korean case of choleste-
rosis bulbi concurrent with elevated intraocular pressure 
(IOP) and rubeosis iridis, which was treated by pars plana vi-
trectomy, anterior chamber irrigation, and intravitreal in-
jection of bevacizumab (Avastin), and include a review of the 
relevant literature.
Case Report
Initially, a 28-year-old man had visited our hospital com-
plaining of poor vision and a white pupil in his right eye in 
August, 2001. He had been diagnosed as having a hyper-
mature cataract, presumed to be congenital, and an exotropia 
of 40 prism diopters in his right eye. B-scan ultrasonography 
showed a flat retina without vitreous floaters in the right eye. 
Uncomplicated irrigation and aspiration without intraocular 
lens implantation and strabismus surgery had been performed 
on his right eye in September and October, 2001, respectively. 
The postoperative best-corrected visual acuity (BCVA) was 
0.02 in the right eye because of profound amblyopia and was 
1.0 in the left eye. Postoperatively, the anterior segment was 
clear and the retina was flat with a long axial length of 30.45 
mm in the right eye. His left eye was normal.
 The subject was lost to follow-up for eight years, and re-
visited our clinic presenting with a two-month history of a 
painful, blind right eye in August, 2009. The BCVA was no 
light perception in the right eye and 1.0 in the left eye. 
Ophthalmologic examination revealed numerous polychromatic J Park, et al. Cholesterosis Bulbi with Secondary Glaucoma
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Fig. 1. (A) Preoperative anterior segment photograph of affected eye. A huge amount of crystals was noted in the anterior 
chamber, and some of the crystals were adhered to the iris surface or sedimented at the inferior angle, resembling a 
pseudohypopyon. (B) On the gonioscopic view, the trabecular meshwork was obscured by dense precipitates of crystals all 
over the angle. (C) A funnel-shaped retinal detachment was found upon B-scan ultrasonography. (D) Anterior segment photo-
graph at one week post-operative. Iris neovascularization had started to regress, but the amount of crystals in the anterior 
chamber had not decreased markedly as compared with the preoperative status, due to the continuous influx of cholesterol 
crystals from the vitreous cavity.
crystals in the anterior chamber and vitreous cavity, unilat-
erally elevated IOP (39 mmHg), mild rubeosis iridis, and sur-
gical aphakia in his right eye. A huge quantity of crystals was 
floating in the anterior chamber according to eye movements, 
and some of the crystals were adhered to the iris surface or 
sedimented at the inferior angle, resembling a pseudohy-
popyon (Fig. 1A). On the gonioscopic view, the patient’s tra-
becular meshwork was obscured by dense precipitates of 
crystals all over the angle and scattered peripheral anterior 
synechiae (Fig. 1B). A mild rubeosis iridis was evident near 
the pupil margin, but the neovascularization of the anterior 
chamber angle could not be clearly confirmed due to the 
presence of so many crystals near the angle. A funnel-shaped 
total RD was noted on the B-scan ultrasonograph (Fig. 1C). 
Our diagnoses were as follows: 1) cholesterosis bulbi accom-
panied by long-standing RD and 2) presumed neovascular 
glaucoma or secondary glaucoma associated with trabecular 
obstruction by crystals. The patient was in good health. 
Routine laboratory results, including serum lipid profiles, 
were within normal limits. 
Anti-glaucoma medication failed to lower the IOP to a 
comfortable level in the patient’s right eye. Pars plana vi-
trectomy and anterior chamber irrigation were performed to 
remove abundant crystal clumps, in conjunction with intra-
vitreal injection of bevacizumab (Avastin, 2.5 mg / 0.1 mL) 
to diminish the neovascularization of the iris on the right eye. 
During the pars plana vitrectomy, we observed many crystals 
floating in the vitreous. Although there was total RD, we 
could not find any retinal breaks due to the hazy media and 
proliferative vitreoretinopathy changes in the retina. Despite 
our efforts, we could not remove the cholesterol crystals com-
pletely due to a continuous influx of the crystals. Microscopic 
analysis of the unprocessed aqueous humor aspirate dis-
closed transparent rhomboidal crystals with notched corners 
that are typical of cholesterol (Fig. 2). Calcium oxalate crys-
tals were not found in the aqueous sample. A week after the 
surgery, the iris neovascularization started to regress, but the 
amount of crystals in the anterior chamber did not decrease 
markedly as compared with the preoperative status, due to 
the continuous influx of cholesterol crystals from the vitre-
ous cavity (Fig. 1D). The IOP was still as high as 40 mmHg 
despite maximal medical treatment. A month after the sur-
gery, the rubeosis iridis had completely disappeared and the 
IOP had decreased to normal range so that the patient could 
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Fig. 2. Microscopic analysis of unprocessed aqueous humor aspi-
rate disclosed transparent rhomboidal crystals with notched corners 
that are typical of cholesterol.
discontinue the administration of all of the IOP-lowering 
agents in the right eye. During the four months post-oper-
ative, the IOP in the right eye has been maintained at an ad-
equate level. 
Discussion
Intraocular cholesterosis is a rare phenomenon that can oc-
cur in eyes that have undergone severe trauma, intraocular 
hemorrhage, severe inflammation, or chronic retinal detach-
ment [5,7]. Forsius [3] reported on a typical microscopic 
photograph of cholesterol crystals in the aqueous humor of 
patients with cholesterosis bulbi. Also, a microscopic and 
chemical study by Kumar [6] suggested that the crystals in 
the anterior chamber were cholesterol. Andrews et al. [8] 
confirmed that the crystalline material observed in cases of 
cholesterosis bulbi was indeed cholesterol by thin-layer 
chromatography. 
The concentration of cholesterol in normal vitreous was 
reported to be much lower than that in normal blood [8]. The 
major source of intraocular cholesterol crystals has been iden-
tified as degenerating extravascular blood [5,7]. Pathological 
changes in the blood-aqueous barrier may allow cholesterol 
to enter the vitreous or the anterior chamber, or it may enter 
via intraocular hemorrhages. Aphakia and lens subluxation 
can promote the anterior migration of cholesterol within the 
eye [9]. Kennedy [9] suggested that anterior chamber choles-
terosis may develop in eyes with chronic retinal detachments 
in the absence of detectable intraocular hemorrhage. In such 
cases, it is likely that the crystals diffuse into the anterior 
chamber through retinal breaks from the subretinal fluid, 
which is rich in cholesterol [2,5]. In the same manner, Coats’ 
disease with exudative retinal detachment can also be a cause 
of anterior chamber cholesterosis [4,10]. Finally, phacolysis 
is reported to be another source of the anterior chamber cho-
lesterol crystals [9,11,12]. Hubbersty and Gourlay [12] described 
three cases of the anterior chamber crystals with lenticular 
origins that were associated with hypermature cataracts and 
lens capsular dehiscence. 
In Korea, three cases of intraocular cholesterosis have 
been reported to our knowledge. Yu et al. [13] first reported a 
16-year-old male patient who had anterior chamber cholesterosis 
in the high myopic and exotropic eye with a visual acuity of 
0.1. He had not suffered from ocular trauma, retinal detachment, 
or intraocular surgery. The other two patients were reported 
by Shyn et al. [14]: a 25-year-old male patient, who had ex-
perienced a penetrating injury by a piece of metallic foreign 
body at the age of 13, underwent an intraocular foreign body 
removal and a lens extraction due to traumatic cataract; and a 
21-year-old female patient had a long-standing cataract in the 
affected eye. The latter two patients had BCVAs of no light 
perception, and they had no evidence of retinal detachment. 
In all three cases, IOPs were normal and the typical choles-
terol crystals in the aqueous aspirates were confirmed by wet 
field light microscopy.  
Among the Korean cases, our patient is the only one that 
had cholesterosis bulbi following long-standing RD, which 
accompanied an elevated IOP. It is not certain which factors 
contributed to IOP elevation in our patient; the abundant cho-
lesterol crystals that settled down at the anterior chamber angle 
could have caused an inflammatory reaction and disturbed 
the aqueous outflow, or the concurrent neovascularization of 
the iris and probably the angle by long-standing RD might 
have raised the IOP. After the pars plana vitrectomy, anterior 
chamber irrigation, and intravitreal injection of bevacizumab 
were performed in the affected eye, abundant crystals still 
existed in the anterior chamber, although their quantity was 
reduced as compared with the preoperative status. Therefore, 
we could not confirm the angle status or the regression of an-
gle neovascularization by gonioscopy. However, iris neo-
vascularization regressed completely, and IOP returned to 
the normal range. This suggests that the predominant mecha-
nism responsible for the acute rise of IOP was the obstruction 
of the trabecular outflow by new vessels. 
Historically, enucleation was mainly performed on pa-
tients with cholesterosis bulbi due to the absence of effective 
treatment, or out of concern for sympathetic inflammation of 
the other eye [3,5,6,13]. Eibschitz-Tsimhoni et al. [10] re-
ported a case that had uncontrolled secondary open-angle 
glaucoma from the anterior chamber cholesterosis associated 
with Coats’ disease. They suggested that the removal of the 
cholesterol crystals and treatment of the anomalous vessels 
by pars plana vitrectomy and endolaser photocoagulation 
may be sufficient to control the IOP. Our case showed that the 
treatment of the new vessels of the iris and anterior chamber 
angle and possibly abnormal retinal vessels by the injection 
of bevacizumab, which is a well-known antagonist of vas-
cular endothelial growth factor, was useful for the manage-
ment of secondary IOP elevation caused by new vessels. J Park, et al. Cholesterosis Bulbi with Secondary Glaucoma
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Reducing the amount of crystal clumps in the anterior cham-
ber by pars plana vitrectomy might also have played a role. In 
summary, intravitreal injection of bevacizumab, combined 
with pars plana vitrectomy and anterior chamber irrigation, 
may be a viable alternative for enucleation in the treatment of 
cholesterosis bulbi accompanied by long-standing RD and 
presumed neovascular glaucoma, although a longer follow-up 
period will be required.
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